Novartis Drug SigniforR Recommended by FDA Advisory Committee for Approval

Novartis drug SigniforR recommended by FDA advisory committee for approval

Filed under: drug treatment news 2012

Basel, November 7, 2012 – The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor R (pasireotide) for the treatment of patients with Cushing's …
Read more on Reuters

 

Celebrity Rehab: 5 Stars Who Sought Treatment For Addiction Post-Split

Filed under: drug treatment news 2012

In the aftermath of a difficult breakup, it's not uncommon for people to turn to guilty pleasures such as food, sex and alcohol to help drown out the pain of the split. For regular folks, a little indulgence may be just what the doctor ordered — in …
Read more on Huffington Post

 

Merck Hepatitis C Drug Shows Promise in Study; Abbott Updates Data

Filed under: drug treatment news 2012

… same class of drug as Victrelis, which went on sale last year and generated $ 387 million in sales for the first nine months of 2012. But MK-5172 is designed to be more potent and to carry a higher barrier to treatment resistance than Victrelis …
Read more on Fox Business

 

FDA approves Pfizer drug to treat rheumatoid arthritis

Filed under: drug treatment news 2012

The drug, Xeljanz, known generically as tofacitinib, is approved to treat adults with moderate to severe arthritis who cannot take, or have an inadequate response to, methotrexate, a standard rheumatoid arthritis treatment. Rheumatoid arthritis is an …
Read more on Reuters